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Multipotential hematopoietic stem cells (HSCs) maintain blood-cell formation throughout life. Here,
Metcalf considers the origin and heterogeneity of HSCs, their ability to self-generate, and their com-
mitment to the various hematopoietic lineages.Hematopoietic stem cells (HSCs) are
rare (1 per 105 bone-marrow cells),
small mononuclear cells that tend to
be noncycling or to have long cell cy-
cles. HSCs divide to form more HSC
(self-generation) or to form cells com-
mitted either to lymphocyte formation
(common lymphoid progenitors, CLPs)
or to the formation of myeloid cells
(common myeloid progenitors, CMPs)
(Figure 1). CMPs are large blast cells
that can then form megakaryocyte-
erythroid progenitors (MEPs) commit-
ted to the formation of erythroid and
megakaryocytic progeny. CMPs can
also form more restricted granulo-
cyte-macrophage progenitors (GMPs)
able to generate granulocytic, macro-
phage, and eosinophil progenitors
and, through these lineage-restricted
cells, generate respective mature pop-
ulations (Kondo et al., 1997; Akashi
et al., 2000). Mast-cell progenitors
segregate in CMP populations but
do not pass through the GMP stage
(Chen et al., 2005).
The generation of progeny by an in-
dividual HSC can be sustained for long
periods before the formation of further
HSC ceases. Alternative fates of HSC,
at least in principle, may be persis-
tence in a latent state without division
for the life of the animal or possibly
even apoptotic death. Neither of these
latter possible fates can be docu-
mented with present technology. No
satisfactory in vitro clonal-culture
technique exists for HSCs and, for
this reason, much of the biology of
HSCs has had to be deduced from
an analysis of the multipotential and
lineage-committed progeny of stem
cells that can be analyzed in vitro.
Many of these latter cells appear to
have no capacity for self-generation,
so the cellular mechanisms necessarytoensureself-generationbyHSCremain
obscure or are at present tentatively
based on knowledge coming from an
analysis of embryonic stem cells.
Self-Generation by HSC
The current inability to accurately
quantify stem cells is a major problem
in attempting to analyze questions of
self-generation or the generation of lin-
eage-committed progeny. The gold-
standard definition of an HSC is that
it is a cell able to reconstitute all hema-
topoietic lineages for an extended pe-
riod in a lethally irradiated recipient.
With this technology, it is clear that
HSCs must be able to self-generate
(that is increase the total numbers of
HSCs). With the use of retrovirally
tagged cells, it has also been docu-
mented that single cells are able to
generate cells in all major hematopoi-
etic lineages, both myeloid and lym-
phoid. It is also clear that such repopu-
lation can be sustained for possibly the
life of an animal but that serial trans-
plantation of marrow from such recipi-
ents can usually only be repeated suc-
cessfully three or four times (Metcalf
and Moore, 1971). Therefore, HSCs
do not have an unlimited capacity to
self-generate or to produce differenti-
ating progeny, and serial transplants
ultimately fail. In this sense, HSCs may
not really be capable of genuine self-
generation and may not be equivalent
to embryonic stem cells. Although
good progress has been made in es-
tablishing the importanceof thenuclear
transcription factors Nanog, Oct3/4,
and STAT3 and leukemia inhibitory
factor (LIF) in the self-generation ofmu-
rine embryonic stem cells (Mitsui et al.,
2003; Boyer et al., 2006), the situation
within HSCs must somehow differ be-
cause self-generation is limited.ImmunitFor an HSC to exhibit at least some
level of self-generation together with
a capacity to generate maturing prog-
eny requires asymmetry during cell di-
vision. This might be accomplished by
alternate symmetrical divisions, some
forming two HSC’s and other divisions
generating two daughters, both of
which form differentiating progeny.
However, where this questionwas able
to be approached directly with the
progeny of multipotential progenitor
cells that can then be clonally analyzed
in vitro, asymmetry was the dominant
type of cell division (Suda et al., 1984;
Bru¨mmendorf et al., 1999).
One of the areas of unease about the
current definition of HSCs is that it de-
pends on the use of a lethally irradiated
recipient. In one sense, this is a quite
relevant assay because themost com-
mon clinical use of HSC is in the trans-
plantation of patients whose marrow
has been destroyed by chemotherapy
or irradiation. From the biological
viewpoint, however, the assay is very
demanding on the injected cells and
is occurring in a host animal whose
regulatory mechanisms must, at least
temporarily, be quite abnormal. This
has been used as criticism of the ap-
parent failure of HSCs to achieve more
than three to four sequential transplan-
tation passages. It can be argued that
under less demanding circumstances,
the performance of HSCs might be
much better. Indeed, there are experi-
mental data showing that the standard
assay for HSC in irradiated recipients
can give incorrect information. For ex-
ample, the yolk sac appears to contain
no HSC by the assay in irradiated
recipients. However, yolk-sac cells,
when injected into mildly pretreated
neonatal animals, not only can repopu-
late these mice but can also generatey 26, June 2007 ª2007 Elsevier Inc. 669
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CommentariesFigure 1. Hematopoietic Family Tree Showing how the Mature Cells in the Various Lineages Are Generated by Self-Generating
Hematopoietic Stem Cells
The following abbreviations are used: CFU-s, colony-forming unit-spleen; CMP, common myeloid progenitor; CLP, common lymphoid progenitor,
MEP, megakaryocyte-erythroid progenitor; GMP, granulocyte-macrophage progenitor; BFU-E, burst-forming unit-erythroid; Meg, megakaryocyte;
Eo, eosinophil; G, granulocyte; and M, macrophage.marrow containing HSCs as defined
with the standard irradiation assay
(Yoder andHiatt, 1997). Yolk sacwould
seem to contain ancestral hematopoi-
etic cells that can generate HSC but
are not detectable with a standard
transplantation assay.
It is also possible to question
whether HSCs actually need to be
involved in sustaining normal hemato-
poiesis. The data supporting the im-
portance of HSC are all derived from
studies in irradiated recipients where
there is an urgent demand for mature
cells. Possibly, if different assay sys-
tems had been used, slightly more
mature progeny would prove to be
quite able to sustain hematopoiesis.
In this context, it has become evident
that some mature cells, such as mast
cells, eosinophils, and T and B mem-
ory lymphocytes, have a substantial
capacity for continued proliferation.
Tests on the self-generating capacity
of progenitor cells in general have indi-
cated a little or no capacity for self-670 Immunity 26, June 2007 ª2007 Elsevgeneration, supporting the hierarchical
model headed by an HSC. However,
not all such recloning experiments are
negative.
At present, there are no overwhelm-
ing reasons to reject the model in Fig-
ure 1, but there are reasons to view
it with certain reservations. Matters
may not be quite as inflexible as por-
trayed in the figure, and this is so be-
fore any consideration of the possible
ability of hematopoietic cells to reverse
differentiation to less mature and pos-
sibly more multipotential cells (Ques-
enberry et al., 2005).
These cautionary remarks may sur-
prise many who accept without ques-
tion the validity of the comforting fam-
ily tree in Figure 1, but there are now
increasing numbers of mutant model
mice in which the generation of various
hematopoietic subsets is very difficult
to explain if the family tree in Figure 1
is rigidly adhered to. The situation
documented in a number of mutant
mouse strains indicates that muchier Inc.variability and flexibility exists in the
capacity of stem cells to sustain hema-
topoiesis. For example, mice lacking
mpl the receptor for thrombopoietin
have severely reduced numbers of
repopulating cells that function poorly
in transplantation tests. However, pro-
genitor-cell numbers in these mice
are less subnormal, and the animal
achieves near normal numbers of cir-
culating mature neutrophils and lym-
phocytes and remains permanently
severely thrombocytopenic (Alexan-
der et al., 1996). This same mouse
demonstrates that repopulating cells
are dependent on stimulation by a
circulating hematopoietic regulator—
thrombopoietin.
Heterogeneity and Origin of HSC
The variability exhibited in progeny
formation by HSC is linked to the likely
existence of heterogeneity in these
populations (Quesenberry et al., 2005).
With the best flow-cytometry-fraction-
ation protocols, a uniform population
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and an engraftment capacity has been
claimed for all such cells (Benveniste
et al., 2003). However, clonal analyses,
combining the stem cell with compet-
ing marrow cells, indicated a marked
heterogeneity in repopulating capacity
with levels of chimerism varying from
1%–95%with the competitive prolifer-
ative capacity being heritable (Sieburg
et al., 2006).
Much recent interest has been
roused by reports that marrow-derived
cells can provide parenchymal cells for
damaged organs such as the liver,
heart, skeletal muscle, and lung. In de-
manding experiments, single purified
cells have been shown to be capable
of repopulating both hematopoietic tis-
suesandmultiplenonhematopoieticor-
gans (Krause et al., 2001). The situation
is complex because of the presence in
marrow populations of mesenchymal
stem cells and possibly organ-specific
stem cells, some of which may share
some surface receptors with HSCs.
The question awaits resolution, but it
seems likely that truly multipotential
cells may be rare and that most genu-
ine HSC are restricted to the genera-
tion of hematopoietic cells.
The full implications of the observed
variability in the repopulating capacity
of HSCs remain obscure. Itmay indeed
indicate intrinsic differences in the pro-
liferative or cell-generating capacity
between individual HSC. Equally, it
may to a degree be the consequence
of variable exposure of the repopulat-
ing stem cells to optimal combinations
of stromal and circulating regulatory
molecules. If the heterogeneity is intrin-
sic, then the origin of this heterogeneity
needs to be sought in earlier cell types,
such as the hemangioblasts that pre-
sumably are the immediate precursors
of HSCs.
It has become an article of faith that
HSCs are generated only once in life
during early embryogenesis. Opinions
are still divided as to whether the orig-
inal source of the HSC is the yolk sac
(Metcalf and Moore, 1971) or the intra-
embryonic aortic gonadal mesoneph-
ros (AGM) area (Godin et al., 1995). If
the yolk sac is the true source, then
clearly the generation of HSCs can
only occur during a limited phase in
yolk-sac development and thereafterthe HSC formed at that time must sus-
tain hematopoiesis for life. The same
may be true if the organ source of
HSC is the AGM. However, the AGM
is within the body, and therefore there
is at least a theoretical possibility that
de novo formation of HSCs might later
be able to occur in emergency circum-
stances.
Progenitor-Cell Formation
The formation of progenitor cells in the
various lineages will be discussed in
detail in the articles to follow in this
issue of Immunity. For avoiding dupli-
cation, these will not be discussed in
detail, but some general comments
can be made about the broad pro-
cesses that need to occur. The de-
scriptions depend heavily on experi-
mental data from multipotential cells
that can be analyzed in vitro but that
are likely to be more mature than repo-
pulating cells. How far these events
can be extrapolated back to repopu-
lating cells is necessarily speculative.
The likely existence of heterogeneity
in HSCs makes it imperative to design
experiments that can be undertaken
with single cells and that have an abil-
ity to track and characterize the imme-
diate progeny of these cells. Above all,
it is necessary to be able to distinguish
an induced change from merely the
selective survival of a particular sub-
set. Regrettably, few studies meet
these criteria and the variety of avail-
able information has to be regarded
with reservations.
It was initially popular to regard
differentiation commitment in HSCs
or multipotential cells as inflexible sto-
chastic processes (Till et al., 1964).
Where analyses have been made of
the immediate progeny of multipoten-
tial cells, the commitment of such
progeny does indeed appear to be
quite random (Suda et al., 1984). Sim-
ilarly, when HSCs are perturbed as in
mpl-deficient mice, all progenitor-cell
lineages are involved, not merely the
megakaryocytic lineages, as might
have been expected (Alexander et al.,
1996). Conversely, if a bacterial surro-
gate infection is initiated by injection of
bacterial endotoxin, again all lineages
increase in numbers and not merely,
as might have been predicted, the
granulocytic and monocytic lineages.ImmunitThe overall impression is, indeed, that
progenitor-cell generation is a some-
what wasteful random process.
There are nowdata, albeit fromartifi-
cial systems, that show that commit-
ment into particular lineages can be
influencedbyunderexpressionor over-
expression of particular nuclear tran-
scription factors. For example, overex-
pression of RARa leads to monocyte
formationat theexpenseofgranulopoi-
esis (Kastner et al., 2001; Taschner
et al., 2007), overexpression ofGATA-1
converts CLPs to megakaryocyte and
erythroid precursors (Iwasaki et al.,
2003), and underexpression of PU.1
leads to excess granulocyte formation
at the expense of monocyte formation
(Dahl et al., 2003). These are quite arti-
ficial systems, but commitment can be
reproducibly induced with them. It is
reasonable to conclude therefore that
under physiological conditions, the
same events will occur. Commitment
is therefore regulatable. The events
are likely to be highly complex and dif-
ficult to unravel because outcomes are
likely to be determined by particular
combinations of transcription factors
and the context in which active combi-
nations occur (Shivdasani and Orkin,
1996).
There is considerable evidence that
HSCs may transcribe simultaneously
specific proteins for multiple differenti-
ation lineages but that such transcrip-
tion occurs at a very low level. The
action of a consortium of transcription
factors to induce commitment to a par-
ticular lineage leads to enhancement
of the production of the particular pro-
teins appropriate to that lineage with
possible suppression of other tran-
scription events (May and Enver,
2001). Paramount in the commitment
process would be the increased ex-
pression of membrane receptors for
appropriate hematopoietic regulators.
Thereafter, subsequent events such
as more definitive commitment, cell
proliferation, and maturation induction
can be ascribed mainly to the action of
the appropriate consortium of growth
factors whether humoral, paracrine,
or membrane displayed on microenvi-
ronmental cells. These latter actions
will include both permissive elements
allowing the presence and prolifera-
tion of cells of a particular lineagey 26, June 2007 ª2007 Elsevier Inc. 671
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spleen colonies) and selective prolifer-
ative actions that also will dictate the
number and type of hematopoietic
progeny.
If hematopoietic commitment and
self-generation by HSC are events
controllable by nuclear transcription
factors, what controls the production
and action of these transcription fac-
tors? Here, we are in essentially un-
known territory. It presumably must
be possible to signal an HSC to influ-
ence its balance of nuclear transcrip-
tion factors. Are these inducing signals
of more familiarity to embryologists or
are they systems such as the Tie2-
Ang1 (Arai et al., 2004) or the Notch-
1-Delta (Stein et al., 2004) microenvi-
ronmental control system? It is less
likely that these signals include the
conventional hematopoietic regulators
because receptor expression for these
regulators would appear to be the con-
sequence of such signaling. However,
in some experiments, growth factors
were able to alter the relative concen-
trations of nuclear transcription factors
(Dahl et al., 2003).
The comprehensive reviews to fol-
low each gives a detailed description
of the subpopulation heterogeneity
in hematopoietic populations and the
transcriptional controls that regulate
differentiation commitment into the
various hematopoietic lineages and
their subpopulations. Analyses of T
lymphocyte populations are made by
Bhandoola et al. (2007) and Rothen-
berg (2007), whereas a matching anal-
ysis of B lymphocyte heterogeneity
and transcriptional regulation is made
by Hardy et al. (2007) and Nutt and
Kee (2007). Rounding off the reviews
is an analysis of myeloid lineage com-
mitment by Iwasaki and Akashi (2007)
and an analysis of dendritic-cell het-
erogeneity and the commitmentmech-
anisms involved by Wu and Liu (2007).
Most of this work has had to be carried
out on murine cell systems and, for
completion, this collection of reviews
includes some cautionary remarks by
Payne and Crooks (2007) on the likely
differences between murine and hu-
man cell systems.
We takemuch for granted when car-
rying out a routine HSC transplanta-
tion, simply because matters appear672 Immunity 26, June 2007 ª2007 Elseto proceed with such reproducibility.
We forget the heterogeneity of the cells
in use, the niches that injected cells
must somehow find, and the signals
needed to be generated by the hema-
topoietic-depleted hosts to stir the in-
jected cells into increased proliferative
activity. The control of stem cell num-
bers, their commitment, and progeny
generation are biological questions of
great clinical importance in many he-
matological diseases. The facts that
stem cells remain frustratingly difficult
to examine and manipulate, let alone
mass produce, are salutory reminders
that we still have much to learn about
hematopoiesis.
ACKNOWLEDGMENTS
Although the agent is not mentioned in the re-
view, the author’s institute shares the patent
for the hematopoietic regulator GM-CSF.
REFERENCES
Akashi, K., Traver, D., Miyamoto, T., and
Weissman, I.L. (2000). A clonogenic common
myeloid progenitor that gives rise to all myeloid
lineages. Nature 404, 193–197.
Alexander, W.S., Roberts, A.W., Nicola, N.A.,
Li, R., and Metcalf, D. (1996). Deficiencies in
progenitor cells of multiple hematopoietic
lineages and defective megakaryocytopoiesis
in mice lacking the thrombopoietin receptor
c-Mpl. Blood 87, 2162–2170.
Arai, F., Hirao, A., Ohmujra, M., Sato, H., Mat-
suoka, S., Takubo, K., Ito, K., Koh, G.Y., and
Suda, T. (2004). Tie2/angiopoietin-1 signaling
regulates hematopoietic stem cell quiescence
in the bone marrow niche. Cell 118, 149–161.
Benveniste, P., Cantin, C., Hyam, D., and
Iscove, N.N. (2003). Hematopoietic stem cells
engraft in mice with absolute efficiency. Nat.
Immunol. 4, 708–713.
Bhandoola, A., von Boehmer, H., Petrie, H.T.,
and Zu´n˜iga-Pflu¨cker, J.C. (2007). Commitment
and developmental potential of extrathymic
and intrathymic T cell precursors: Plenty to
choose from. Immunity 26, this issue,
678–689.
Boyer, L.A., Mathur, D., and Jaenisch, R.
(2006). Molecular control of pluripotency.
Curr. Opin. Genet. Dev. 16, 455–462.
Bru¨mmendorf, T.H., Dragowska, W., and
Lansdorp, P.M. (1999). Asymmetric cell divi-
sions in hematopoietic stem cells. Ann. N Y
Acad. Sci. 872, 265–272.
Chen, C.C., Grimbaldeston, M.A., Tsai, M.,
Weissman, I.L., and Galli, S.J. (2005). Identifi-
cation of mast cell progenitors in adult mice.
Proc. Natl. Acad. Sci. USA 102, 11408–11413.
Dahl, R., Walsh, J.C., Lancki, D., Laslo, P., Iyer,
S.R., Singh, H., and Simon, M.C. (2003). Regu-
lation of macrophage and neutrophil cell fatesvier Inc.by the PU.1:C/EBPalpha ratio and granulocyte
colony-stimulating factor. Nat. Immunol. 4,
1029–1036.
Godin, I., Dieterlen-Lievre, F., and Cumano, A.
(1995). Emergence of multipotent hemopoietic
cells in the yolk sac and paraaortic splanchno-
pleura in mouse embryos, beginning at 8.5
days postcoitus. Proc. Natl. Acad. Sci. USA
92, 773–777.
Hardy, R.R., Kincade, P.W., and Dorshkind, K.
(2007). The protean nature of cells in the B
lymphocyte lineage. Immunity 26, this issue,
703–714.
Iwasaki, H., and Akashi, K. (2007). Myeloid
lineage commitment from the hematopoietic
stem cell. Immunity 26, this issue,
726–740.
Iwasaki, H., Mizuno, S., Wells, R.A., Cantor,
A.B., Watanabe, S., and Akashi, K. (2003).
GATA-1 converts lymphoid and myelomono-
cytic progenitors into the megakaryocyte/
erythrocyte lineages. Immunity 19, 451–462.
Kastner, P., Lawrence, H.J., Waltzinger, C.,
Ghyselinck, N.B., Chambon, P., and Chan, S.
(2001). Positive and negative regulation of
granulopoiesis by endogenous RARalpha.
Blood 97, 1314–1320.
Kondo, M., Weissman, I.L., and Akashi, K.
(1997). Identification of clonogenic common
lymphoid progenitors in mouse bone marrow.
Cell 91, 661–672.
Krause, D.S., Theise, N.D., Collector, M.I., He-
negariu, O., Hwang, S., Gardner, R., Neutzel,
S., and Sharkis, S.J. (2001). Multi-organ,
multi-lineage engraftment by a single bone
marrow-derived stem cell. Cell 105, 369–377.
May, G., and Enver, T. (2001). The lineage
commitment and self-renewal of blood stem
cells. In Hematopoiesis: A Developmental
Approach., L.I. Zon, ed. (New York: Oxford
University Press).
Metcalf, D., and Moore, M.A.S. (1971). Hema-
topoietic Cells (Amsterdam: North-Holland).
Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K.,
Murakami, M., Takahashi, K., Maruyama, M.,
Maeda, M., and Yamanaka, S. (2003). The ho-
meoprotein Nanog is required for maintenance
of pluripotency in mouse epiblast and ES cells.
Cell 113, 631–642.
Nutt, S.L., and Kee, B.L. (2007). The transcrip-
tional regulation of B cell lineage commitment.
Immunity 26, this issue, 715–725.
Payne, K., and Crooks, G.M. (2007). Immune
cell lineage commitment: Translation from
mouse to human. Immunity 26, this issue,
674–677.
Quesenberry, P.J., Dooner, G., Colvin, G., and
Abedi, M. (2005). Stem cell biology and the
plasticity polemic. Exp. Hematol. 33, 389–394.
Rothenberg, E.V. (2007). Negotiation of the T
lineage fate decision by transcription-factor in-
terplay and microenvironmental signals. Im-
munity 26, this issue, 690–702.
Shivdasani, R.A., and Orkin, S.H. (1996). The
transcriptional control of hematopoiesis. Blood
87, 4025–4039.
Immunity
CommentariesSieburg, H.B., Cho, R.H., Dykstra, B., Uchida,
N., Eaves, C.J., and Muller-Sieburg, C.E.
(2006). The hematopoietic stem compartment
consists of a limited number of discrete stem
cell subsets. Blood 107, 2311–2316.
Stein, M.I., Zhu, J., and Emerson, S.G. (2004).
Molecular pathways regulating the self-renewal
of hematopoietic stem cells. Exp. Hematol. 32,
1129–1136.
Suda, T., Suda, J., and Ogawa, M. (1984).
Disparate differentiation in mouse hemopoi-etic colonies derived from paired progeni-
tors. Proc. Natl. Acad. Sci. USA 81, 2520–
2524.
Taschner, S., Koesters, C., Platzer, B., Jorgl,
A., Ellmeier, W., Benesch, T., and Strobl, H.
(2007). Down-regulation of RXRalpha expres-
sion is essential for neutrophil development
from granulocyte/monocyte progenitors.
Blood 109, 971–979.
Till, J.E., McCulloch, E.A., and Siminovitch, L.
(1964). A stochastic model of stem cell prolifer-Immunitation, based on the growth of spleen colony-
forming cells. Proc. Natl. Acad. Sci. USA 51,
29–36.
Wu, L., and Liu, Y.-J. (2007). Development of
dendritic cell lineages. Immunity 26, this issue,
741–750.
Yoder, M.C., and Hiatt, K. (1997). Engraftment
of embryonic hematopoietic cells in condi-
tioned newborn recipients. Blood 89, 2176–
2183.y 26, June 2007 ª2007 Elsevier Inc. 673
